Revised Intimation (Including Resignation Letter) Resignation of Non Executive Independent Director under Regulation 30 of the SEBI(LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mrs. Deepika Krishnan Iyer (DIN: 10515778) has resigned as a Non-Executive Independent Director of Welcure Drugs & Pharmaceuticals Ltd, effective from the close of business hours on 06th August 2025. The reason cited is pre-occupation — she is unable to dedicate sufficient time to the company's affairs. She has confirmed there are no other material reasons behind her exit. The Board has recorded its appreciation for her tenure and contribution. The intimation has been filed under Regulation 30 of the SEBI (LODR) Regulations, 2015, along with her resignation letter.
This is a routine board-level change with no governance red flags or disclosed material concerns. Shareholders may view it as neutral, though the company will need to fill the independent director seat to maintain board composition compliance.